Find UNII-B7XF2TD73C manufacturers, exporters & distributors on PharmaCompass

PharmaCompass

Synopsis

Synopsis

ACTIVE PHARMA INGREDIENTS

0

CEP/COS

CEP/COS Certifications

0

JDMF

JDMFs Filed

0

KDMF

KDMF

0

VMF

NDC API

API REF. PRICE (USD/KG)

$
$ 0

MARKET PLACE

0

API

0

FDF

0INTERMEDIATES

FINISHED DOSAGE FORMULATIONS

0

FDF Dossiers

FDF Dossiers

0

FDA Orange Book

FDA (Orange Book)

0

Europe

Europe

0

Canada

Canada

0

Australia

Australia

0

South Africa

South Africa

0

Listed Dossiers

Listed Dossiers

0 DRUGS IN DEVELOPMENT

FDF Dossiers

DRUG PRODUCT COMPOSITIONS

REF. STANDARDS OR IMPURITIES

0

EDQM

0

USP

0

JP

PATENTS & EXCLUSIVITIES

0

US Patents

0

US Exclusivities

0

Health Canada Patents

DIGITAL CONTENT

0

Data Compilation #PharmaFlow

0

Stock Recap #PipelineProspector

0

Weekly News Recap #Phispers

0

News #PharmaBuzz

GLOBAL SALES INFORMATION

US Medicaid

NA

Annual Reports

NA

Finished Drug Prices

NA

46 RELATED EXCIPIENT COMPANIES

96EXCIPIENTS BY APPLICATIONS

Chemistry

Click the arrow to open the dropdown
read-moreClick the button for full data set
Also known as: 220988-26-1, B7xf2td73c, 2-cyclopropyl-7-methyl-2,4,9,15-tetrazatricyclo[9.4.0.03,8]pentadeca-1(11),3,5,7,12,14-hexaen-10-one;hydrate, Unii-b7xf2td73c, Schembl1923903, Dtxsid30176606
Molecular Formula
C30H30N8O3
Molecular Weight
550.6  g/mol
InChI Key
KMTLSXAXTLQBKJ-UHFFFAOYSA-N
FDA UNII
B7XF2TD73C

UNII-B7XF2TD73C
A potent, non-nucleoside reverse transcriptase inhibitor used in combination with nucleoside analogues for treatment of HIV INFECTIONS and AIDS.
1 2D Structure

UNII-B7XF2TD73C

2 Identification
2.1 Computed Descriptors
2.1.1 IUPAC Name
2-cyclopropyl-7-methyl-2,4,9,15-tetrazatricyclo[9.4.0.03,8]pentadeca-1(11),3,5,7,12,14-hexaen-10-one;hydrate
2.1.2 InChI
InChI=1S/2C15H14N4O.H2O/c2*1-9-6-8-17-14-12(9)18-15(20)11-3-2-7-16-13(11)19(14)10-4-5-10;/h2*2-3,6-8,10H,4-5H2,1H3,(H,18,20);1H2
2.1.3 InChI Key
KMTLSXAXTLQBKJ-UHFFFAOYSA-N
2.1.4 Canonical SMILES
CC1=C2C(=NC=C1)N(C3=C(C=CC=N3)C(=O)N2)C4CC4.CC1=C2C(=NC=C1)N(C3=C(C=CC=N3)C(=O)N2)C4CC4.O
2.2 Other Identifiers
2.2.1 UNII
B7XF2TD73C
2.3 Synonyms
2.3.1 MeSH Synonyms

1. Bi Rg 587

2. Bi-rg-587

3. Birg587

4. Hemihydrate, Nevirapine

5. Nevirapine

6. Viramune

2.3.2 Depositor-Supplied Synonyms

1. 220988-26-1

2. B7xf2td73c

3. 2-cyclopropyl-7-methyl-2,4,9,15-tetrazatricyclo[9.4.0.03,8]pentadeca-1(11),3,5,7,12,14-hexaen-10-one;hydrate

4. Unii-b7xf2td73c

5. Schembl1923903

6. Dtxsid30176606

7. Nevirapine Hemihydrate [usp-rs]

8. Nevirapine Hemihydrate [who-dd]

9. Nevirapine Hemihydrate [who-ip]

10. Nevirapine Hemihydrate [ep Monograph]

11. Nevirapine Hemihydrate [usp Monograph]

12. Nevirapinum Hemihydrate [who-ip Latin]

13. Q27274473

14. 6h-dipyrido(3,2-b:2',3'-e)(1,4)diazepin-6-one, 11-cyclopropyl-5,11-dihydro-4-methyl-, Hydrate (2:1)

2.4 Create Date
2006-10-25
3 Chemical and Physical Properties
Molecular Weight 550.6 g/mol
Molecular Formula C30H30N8O3
Hydrogen Bond Donor Count3
Hydrogen Bond Acceptor Count9
Rotatable Bond Count2
Exact Mass550.24408685 g/mol
Monoisotopic Mass550.24408685 g/mol
Topological Polar Surface Area117 Ų
Heavy Atom Count41
Formal Charge0
Complexity397
Isotope Atom Count0
Defined Atom Stereocenter Count0
Undefined Atom Stereocenter Count0
Defined Bond Stereocenter Count0
Undefined Bond Stereocenter Count0
Covalently Bonded Unit Count3
4 Pharmacology and Biochemistry
4.1 MeSH Pharmacological Classification

Anti-HIV Agents

Agents used to treat AIDS and/or stop the spread of the HIV infection. These do not include drugs used to treat symptoms or opportunistic infections associated with AIDS. (See all compounds classified as Anti-HIV Agents.)


Cytochrome P-450 CYP3A Inducers

Drugs and compounds that induce the synthesis of CYTOCHROME P-450 CYP3A. (See all compounds classified as Cytochrome P-450 CYP3A Inducers.)


Reverse Transcriptase Inhibitors

Inhibitors of reverse transcriptase (RNA-DIRECTED DNA POLYMERASE), an enzyme that synthesizes DNA on an RNA template. (See all compounds classified as Reverse Transcriptase Inhibitors.)


Related Excipient Companies

Upload your portfolio for free, ask us

Excipients by Applications

Click here to find the perfect excipient manufacturers by their capabilities

Solubilizers

read-more
read-more

Film Formers & Plasticizers

read-more
read-more

Thickeners and Stabilizers

read-more
read-more

Parenteral

read-more
read-more

Topical

read-more
read-more

Coating Systems & Additives

read-more
read-more

Taste Masking

read-more
read-more

Controlled & Modified Release

read-more
read-more

Emulsifying Agents

read-more
read-more

Fillers, Diluents & Binders

read-more
read-more

Direct Compression

read-more
read-more

Granulation

read-more
read-more

Surfactant & Foaming Agents

read-more
read-more

Co-Processed Excipients

read-more
read-more

Chewable & Orodispersible Aids

read-more
read-more

API Stability Enhancers

read-more
read-more

Soft Gelatin

read-more
read-more

Rheology Modifiers

read-more
read-more

REF. STANDARDS & IMPURITIES

Upload your portfolio for free, ask us

ABOUT THIS PAGE

UNII-B7XF2TD73C Manufacturers

A UNII-B7XF2TD73C manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of UNII-B7XF2TD73C, including repackagers and relabelers. The FDA regulates UNII-B7XF2TD73C manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. UNII-B7XF2TD73C API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.

click here to find a list of UNII-B7XF2TD73C manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.

UNII-B7XF2TD73C Suppliers

A UNII-B7XF2TD73C supplier is an individual or a company that provides UNII-B7XF2TD73C active pharmaceutical ingredient (API) or UNII-B7XF2TD73C finished formulations upon request. The UNII-B7XF2TD73C suppliers may include UNII-B7XF2TD73C API manufacturers, exporters, distributors and traders.

click here to find a list of UNII-B7XF2TD73C suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.

UNII-B7XF2TD73C USDMF

A UNII-B7XF2TD73C DMF (Drug Master File) is a document detailing the whole manufacturing process of UNII-B7XF2TD73C active pharmaceutical ingredient (API) in detail. Different forms of UNII-B7XF2TD73C DMFs exist exist since differing nations have different regulations, such as UNII-B7XF2TD73C USDMF, ASMF (EDMF), JDMF, CDMF, etc.

A UNII-B7XF2TD73C DMF submitted to regulatory agencies in the US is known as a USDMF. UNII-B7XF2TD73C USDMF includes data on UNII-B7XF2TD73C's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The UNII-B7XF2TD73C USDMF is kept confidential to protect the manufacturer’s intellectual property.

click here to find a list of UNII-B7XF2TD73C suppliers with USDMF on PharmaCompass.

UNII-B7XF2TD73C WC

A UNII-B7XF2TD73C written confirmation (UNII-B7XF2TD73C WC) is an official document issued by a regulatory agency to a UNII-B7XF2TD73C manufacturer, verifying that the manufacturing facility of a UNII-B7XF2TD73C active pharmaceutical ingredient (API) adheres to the Good Manufacturing Practices (GMP) regulations of the importing country. When exporting UNII-B7XF2TD73C APIs or UNII-B7XF2TD73C finished pharmaceutical products to another nation, regulatory agencies frequently require a UNII-B7XF2TD73C WC (written confirmation) as part of the regulatory process.

click here to find a list of UNII-B7XF2TD73C suppliers with Written Confirmation (WC) on PharmaCompass.

UNII-B7XF2TD73C NDC

National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing UNII-B7XF2TD73C as an active pharmaceutical ingredient (API).

Finished drug products

The FDA updates the NDC directory daily. The NDC numbers for UNII-B7XF2TD73C API and other APIs are published in this directory by the FDA.

Unfinished drugs

The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.

Pharmaceutical companies that manufacture UNII-B7XF2TD73C as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.

Compounded drug products

The NDC directory also contains data on finished compounded human drug products that contain UNII-B7XF2TD73C and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a UNII-B7XF2TD73C NDC to their finished compounded human drug products, they may choose to do so.

click here to find a list of UNII-B7XF2TD73C suppliers with NDC on PharmaCompass.

UNII-B7XF2TD73C GMP

UNII-B7XF2TD73C Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.

GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).

PharmaCompass offers a list of UNII-B7XF2TD73C GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right UNII-B7XF2TD73C GMP manufacturer or UNII-B7XF2TD73C GMP API supplier for your needs.

UNII-B7XF2TD73C CoA

A UNII-B7XF2TD73C CoA (Certificate of Analysis) is a formal document that attests to UNII-B7XF2TD73C's compliance with UNII-B7XF2TD73C specifications and serves as a tool for batch-level quality control.

UNII-B7XF2TD73C CoA mostly includes findings from lab analyses of a specific batch. For each UNII-B7XF2TD73C CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.

UNII-B7XF2TD73C may be tested according to a variety of international standards, such as European Pharmacopoeia (UNII-B7XF2TD73C EP), UNII-B7XF2TD73C JP (Japanese Pharmacopeia) and the US Pharmacopoeia (UNII-B7XF2TD73C USP).

Inform the supplier about your product requirements, specifying if you need a product with particular monograph like EP (Ph. Eur.), USP, JP, BP, or any other quality. In addition, clarify whether you need hydrochloride (HCl), anhydricum, base, micronisatum or a specific level of purity. To find reputable suppliers, utilize the filters and select those certified by GMP, FDA, or any other certification as per your requirement.
For your convenience, we have listed synonyms and CAS numbers to help you find the best supplier. The use of synonyms and CAS numbers can be helpful in identifying potential suppliers, but it is crucial to note that they might not always indicate the exact same product. It is important to confirm the product details with the supplier before making a purchase to ensure that it meets your requirements.
Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty